# Rein Therapeutics Inc. (RNTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RNTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -12.21M | $ -12.06M | N/A | $ 10.20M |
| 2025 | $ 0 | $ -51.06M | $ -19.82M | $ 0 | $ 16.92M |
| 2024 | $ 0 | $ -49.24M | $ -23.43M | $ 0 | $ 54.39M |
| 2023 | $ 0 | $ -11.8K | $ -10.18M | $ 48.0K | $ 6.89M |
| 2022 | N/A | N/A | $ -27.78M | $ 33.0K | $ 18.62M |
| 2021 | N/A | N/A | $ -28.42M | $ 162.0K | $ 43.90M |
| 2020 | N/A | N/A | $ -26.09M | $ 387.0K | $ 12.16M |
| 2019 | N/A | N/A | $ -34.37M | $ 5.03M | $ 16.05M |
| 2018 | N/A | N/A | $ -42.72M | $ 5.34M | $ 19.60M |
| 2017 | N/A | N/A | $ -27.85M | $ 0 | $ 47.80M |
| 2016 | N/A | N/A | $ -20.66M | $ 0 | $ -111.81M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 5.47 |
| Current Ratio | 4.27 |

## Other views

- [Metrics](https://sponda.capital/en/RNTX.md)
- [Charts](https://sponda.capital/en/RNTX/charts.md)
- [Compare](https://sponda.capital/en/RNTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.